Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples